Chemoembolization and bland embolization: A critical appraisal

Clinics in Liver Disease

Volumn 9, Issue 2, 2005, Pages 287-300

  Befeler, Alex S ^a  

^a SAINT LOUIS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CARBOPLATIN; CISPLATIN; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; GELFOAM; IODINATED POPPYSEED OIL; LIDOCAINE; MITOMYCIN C; POLYVINYL ALCOHOL SPONGE; SEDATIVE AGENT; TAMOXIFEN;

ABDOMINAL PAIN; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTIFICIAL EMBOLISM; BLAND EMBOLIZATION; CANCER SURGERY; CANCER SURVIVAL; CHEMOEMBOLIZATION; CLINICAL TRIAL; CONFERENCE PAPER; FEVER; HUMAN; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; META ANALYSIS; PREDICTION; RADIOFREQUENCY ABLATION; TECHNIQUE; TREATMENT PLANNING; VOMITING;

EID: 17144404204     PISSN: 10893261     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cld.2004.12.011     Document Type: Conference Paper

References (78)

1. D.M. Parkin, F. Bray, and J. Ferlay Estimating the world cancer burden: Globocan 2000 Int J Cancer 94 2001 153 156
2. L. Benvegnù, M. Gios, and S. Boccato Natural history of compensated viral cirrhosis: a prospective study on the incidence and hierarchy of major complication Gut 53 2004 744 749
3. H. El-Serag, J. Davila, and N. Petersen The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update Ann Intern Med 139 10 2003 817 823
4. J. Llovet, A. Burroughs, and J. Bruix Hepatocellular carcinoma Lancet 362 2003 1907 1917
5. A. Befeler, and A. Di Bisceglie Hepatocellular carcinoma: diagnosis and treatment Gastroenterology 122 2002 1609 1619
6. J. Llovet, C. Brú, and J. Bruix Prognosis of hepatocellular carcinoma: the BCLC staging classification Semin Liver Dis 19 3 1999 329 338
7. D. Lin, Y. Liaw, and T. Lee Hepatic arterial embolization in patients with unresectable hepatocellular carcinoma-a randomized controlled trial Gastroenterology 94 1988 453 456
8. Anonymous A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma N Engl J Med 332 19 1995 1256 1261
9. J. Bruix, J.M. Llovet, and A. Castells Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized, controlled trial in a single institution Hepatology 27 1998 1578 1583
10. C. Lo, H. Ngan, and W. Tso Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma Hepatology 35 2002 1164 1171
11. J.M. Llovet, M.I. Real, and X. Montañá Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomized controlled trial Lancet 359 2002 1734 1739
12. G. Pelletier, A. Roche, and O. Ink A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma J Hepatol 11 2 1990 181 184
13. G. Pelletier, M. Ducreaux, and F. Gay Treatment of unresectable hepatocellular carcinoma with lipidol chemoembolization: a multicenter randomized trial J Hepatol 29 1998 129 134
14. C. Camma, F. Schepis, and A. Orlando Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials Radiology 224 1 2002 47 54
15. J. Llovet, and J. Bruix Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival Hepatology 37 2003 429 442
16. P. Mathurin, O. Rixe, and N. Carbonell Overview of medical treatments in unresectable hepatocellular carcinoma-an impossible meta-analysis? Aliment Pharmacol Ther 12 1998 111 126
17. R.G. Simonetti, A. Liberati, and C. Angiolini Treatment of hepatocellular carcinoma: a systematic review of randomized controlled trials Ann Oncol 8 2 1997 117 136
18. C. Breedis, and G. Young The blood supply of neoplasm of the liver Am J Pathol 30 1954 969 985
19. T. Higuchi, M. Kikuchi, and M. Okazaki Hepatocellular carcinoma after transcatheter hepatic arterial embolization: a histopathologic study of 84 resected cases Cancer 73 9 1994 2259 2267
20. D. Ramsey, L. Kernagis, and M. Soulen Chemoembolization of hepatocellular carcinoma J Vasc Interv Radiol 13 2002 S211 S221
21. T. Konno Targeting cancer chemotherapeutic agents by use of lipiodol contrast medium Cancer 66 1990 1897 1903
22. R.T. Poon, H. Ngan, and C. Lo Transarterial chemoembolization for inoperable hepatocellular carcinoma and postresection intrahepatic recurrence J Surg Oncol 73 2000 109 114
23. S. Kawai, M. Tani, and J. Okamura Prospective and randomized trial of lipiodol-transcatheter arterial chemoembolization for treatment of hepatocellular carcinoma: a comparison of epirubicin and doxorubicin (second cooperative study) Semin Oncol 24 2 suppl 6 1997 S6-38 S6-45
24. S. Watanabe, M. Nishioka, and Y. Ohta Prospective and randomized controlled study of chemoembolization therapy in patients with advanced hepatocellular carcinoma Cancer Chemother Pharmacol 33 suppl 1994 S93 S96
25. S. Roayaie, J. Frischer, and S. Emre Long-term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinomas larger than 5 centimeters Ann Surg 235 4 2002 533 539
26. Y. Ono, T. Yoshimasu, and R. Ashikaga Long-term results of lipiodol-transcatheter arterial embolization with cisplatin or doxorubicin for unresectable hepatocellular carcinoma Am J Clin Oncol 23 6 2000 564 568
27. K. Kamada, T. Nakanishi, and M. Kitamoto Long-term prognosis of patients undergoing transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: comparison of cisplatin lipiodol suspension and doxorubicin hydrochloride emulsion J Vasc Interv Radiol 12 2001 847 854
28. K. Uenoi, N. Miyazono, and H. Inoue Transcatheter arterial chemoembolization therapy using iodized oil for patients with unresectable hepatocellular carcinoma: evaluation of three kinds of regimens and analysis of prognostic factors Cancer 88 7 2001 1574 1581
29. M.S. Chen, J.Q. Li, and Y.Q. Zhang High-dose iodized oil transcatheter arterial chemoembolization for patients with large hepatocellular carcinoma World J Gastroenterol 8 1 2002 74 78
30. W. Lu, Y. Li, and X. He Transcatheter arterial chemoembolization for hepatocellular carcinoma in patients with cirrhosis: evaluation of two kinds of dosages of anticancer drugs and analysis of prognostic factors Hepatogastroenterology 50 54 2003 2079 2083
31. O. Ernst, G. Sergent, and D. Mizrahi Treatment of hepatocellular carcinoma by transcatheter arterial chemoembolization: comparison of planned periodic chemoembolization and chemoembolization based on tumor response AJR Am J Roentgenol 172 1 1999 59 64
32. A. Chan, M.F. Yuen, and C.K. Hui A prospective study regarding the complications of transcatheter intraarterial lipiodol chemoembolization in patients with hepatocellular carcinoma Cancer 94 6 2002 1747 1752
33. S.H. Lee, S.T. Hath, and S.H. Park Intraarterial lidocaine administration for relief of pain resulting from transarterial chemoembolization of hepatocellular carcinoma: its effectiveness and optimal timing of administration Cardiovas Interven Radiol 24 6 2001 368 371
34. M. Romano, A. Giojelli, and O. Tamburrini Chemoembolization for hepatocellular carcinoma: effect of intraarterial lidocaine in peri- and post-procedural pain and hospitalization Radiol Med (Torino) 105 4 2003 350 355
35. T.I. Huo, J.C. Wu, and Y.H. Huang Acute renal failure after transarterial chemoembolization for hepatocellular carcinoma: a retrospective study of the incidence, risk factors, clinical course and long-term outcome Aliment Pharmacol Ther 19 9 2004 999 1007
36. R. Poon, W.-C. Yu, and S.-T. Fan Long-term oral branched chain amino acids in patients undergoing chemoembolization for hepatocellular carcinoma: a randomized trial Aliment Pharm Ther 19 2004 779 788
37. J. Ioannidis, J. Cappelleri, and J. Lau Issues in comparisons between meta-analyses and large trials JAMA 279 14 1998 1089 1093
38. J. Llovet, J. Bustamante, and A. Castells Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials Hepatology 29 1 1999 62 67
39. E. Villa, A. Moles, and I. Ferretti Natural history of inoperable hepatocellular carcinoma: estrogen receptors' status in the tumor is the strongest prognostic factor for survival Hepatology 32 2 2000 233 238
40. CLIP Investigators Prospective validation of the CLIP score: a new prognostic system for patients with cirrhosis and hepatocellular carcinoma Hepatology 31 4 2000 840 845
41. K. Okuda, T. Ohtsuki, and H. Obata Natural history of hepatocellular carcinoma and prognosis in relation to treatment: study of 850 patients Cancer 56 1995 918 928
42. O. Ernst, G. Sergent, and D. Mizrahi Treatment of hepatocellular carcinoma by transcatheter arterial chemoembolization: comparison of planned periodic chemoembolization and chemoembolization based on tumor response AJR Am J Roentgenol 172 1999 59 64
43. J.M. Chang, W.S. Tzeng, and H.B. Pan Transcatheter arterial embolization with or without cisplatin treatment of hepatocellular carcinoma: a randomized controlled study Cancer 74 9 1994 2449 2453
44. S. Kawai, J. Okamura, and M. Ogawa Prospective and randomized clinical trial for the treatment of hepatocellular carcinoma-a comparison of lipiodol-transcatheter arterial embolization with and without adriamycin (first cooperative study) Cancer Chemotherapy & Phamacol 31 Suppl 1992 S1 S6
45. R. Testa, E. Testa, and E. Giannini Trans-catheter arterial chemobolisation for hepatocellular carcinoma in patients with viral cirrhosis: role of combined staging systems, Cancer Liver Italian Program (CLIP) and Model for End-stage Liver Disease (MELD), in predicting outcome after treatment Aliment Pharmacol Ther 17 2003 1563 1569
46. L. Lladó, J. Virgili, and J. Figueras A prognostic index of the survival of patients with unresectable hepatocellular carcinoma after transcatheter arterial chemoembolization Cancer 88 1 2000 50 57
47. L. Mondazzi, R. Bottelli, and G. Brambilla Transarterial oily chemoembolization for the treatment of hepatocellular carcinoma: a multivariate analysis of prognostic factors Hepatol 19 5 1994 1115 1123
48. C.B. O'Suilleabhain, R.T.P. Poon, and J. Young Factors predictive of 5-year survival after transarterial chemoembolization for inoperable hepatocellular carcinoma Br J Surg 90 2003 325 331
49. C.-C. Wu, Y.-Z. Ho, and W. Ho Preoperative transcatheter arterial chemoembolization for resectable large hepatocellular carcinoma: a reappraisal Br J Surg 82 1 1995 122 126
50. S. Yamasaki, H. Hasegawa, and H. Kinoshita A prospective randomized trial of the preventive effect of preoperative transcatheter arterial embolization against recurrence of hepatocellular carcinoma Jpn J Cancer Res 87 2 1996 206 211
51. F. Paye, P. Jagot, and V. Vilgrain Preoperative chemoembolization of hepatocellular carcinoma: a comparative study Arch Surg 133 7 1998 767 772
52. M. Uchida, H. Kohno, and H. Kubota Role of preoperative transcatheter arterial oily chemoembolization for resectable hepatocellular carcinoma World J Surg 20 1996 326 331
53. T. Harada, K. Matsuo, and T. Inoue Is pre-operative hepatic arterial chemoembolization safe and effective for hepatocellular carcinoma? Ann Surg 224 1 1996 4 9
54. C.D. Lu, S.Y. Peng, and X.C. Jiang Preoperative transcatheter arterial chemoembolization and prognosis of patients with hepatocellular carcinoma: retrospective analysis of 120 cases World J Surg 23 1999 293 300
55. Y.Q. Luo, Y. Wang, and H. Chen Influence of preoperative transcatheter arterial chemoembolization on liver resection in patients with resectable hepatocellular carcinoma Hepatobiliary Pancreat Dis Int 1 4 2002 523 526
56. T. Ochiai, T. Sonoyama, and T. Hironaka Hepatectomy with chemoembolization for treatment of hepatocellular carcinoma Hepatogastroenterology 50 51 2003 750 755
57. H. Sugo, S. Futagawa, and T. Beppu Role of preoperative transcatheter arterial chemoembolization for resectable hepatocellular carcinoma: relation between postoperative course and the pattern of tumor recurrence World J Surg 27 2003 1295 1299
58. P.E. Majno, R. Adam, and H. Bismuth Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis Ann Surg 226 6 1997 688 703
59. V. Di Carlo, G. Ferrari, and R. Castoldi Pre-operative chemoembolization of hepatocellular carcinoma in cirrhotic patients Hepatogastroenterology 45 24 1998 1950 1954
60. G.E. Gerunda, D. Neri, and R. Merenda Role of transarterial chemoembolization before liver resection for hepatocarcinoma Liver Transpl 6 5 2000 619 626
61. V. Mazzaferro, E. Regalia, and R. Doci Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis N Engl J Med 334 1996 693 699
62. J. Figueras, E. Jaurrieta, and C. Valls Survival after liver transplantation in cirrhotic patients with and without hepatocellular carcinoma: a comparative study Hepatology 25 1997 1485 1489
63. H. Bismuth, P. Majno, and R. Adam Liver transplantation for hepatocellular carcinoma Semin Liver Dis 19 1999 311 328
64. J.M. Llovet, J. Bruix, and J. Fuster Liver transplantation for small hepatocellular carcinoma: the tumor-node-metastasis classification does not have prognostic power Hepatology 27 1998 1572 1577
65. J.M. Llovet, J. Fuster, and J. Bruix Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation Hepatology 30 1999 1434 1440
66. F.Y. Yao, N.M. Bass, and B. Nikolai A follow-up analysis of the pattern and predictors of dropout from the waiting list for liver transplantation in patients with hepatocellular carcinoma: implications for current organ allocation policy Liver Transpl 9 7 2002 684 692
67. I. Graziadei, K. Sandmueller, and P. Waldenberger Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome Liver Transpl 9 6 2003 557 563
68. D. Harnois, J. Steers, and J. Andrews Preoperative hepatic artery chemoembolization followed by orthotopic liver transplantation for hepatocellular carcinoma Liver Transpl Surg 5 3 1999 192 199
69. Y. Maddala, L. Stadheim, and J. Andrews Drop-out rates of patients with hepatocellular cancer listed for liver transplantation: outcome with chemoembolization Liver Transpl 10 3 2004 449 455
70. H.M. Richard III, J.E. Silberzweig, and H.A. Mitty Hepatic arterial complications in liver transplant recipients treated with pretransplantation chemoembolization for hepatocellular carcinoma Radiology 214 3 2000 775 779
71. R.B. Freeman, R.H. Wiesner, and J.P. Roberts 2003 SRTR report on the state of transplantation: improving liver allocation: MELD and PELD Am J Transpl 4 suppl 9 2004 114 131
72. United Network for Organ Sharing Policy 3.6 www.unos.org/ policiesandbylaws/policies.asp Accessed September 14, 2004
73. F. Yao, L. Ferrell, and N. Bass Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival Hepatology 33 6 2001 1394 1403
74. K. Kamada, M. Kitamoto, and H. Aikata Combination of transcatheter arterial chemoembolization using cisplatin-lipiodol suspension and percutaneous ethanol injection for treatment of advanced small hepatocellular carcinoma Am J Surg 184 3 2002 284 290
75. M. Koda, Y. Murawaki, and A. Mitsuda Combination therapy with transcatheter arterial chemoembolization and percutaneous ethanol injection compared with percutaneous ethanol injection alone for patients with small hepatocellular carcinoma Cancer 92 6 2001 1516 1524
76. R. Lencioni, A. Paolicchi, and M. Moretti Combined transcatheter arterial chemoembolization and percutaneous ethanol injection for the treatment of large hepatocellular carcinoma: local therapeutic effect and long-term survival rate Eur Radiol 8 3 1998 439 444
77. K. Yamamoto, M. Masuzawa, and M. Kato Evaluation of combined therapy with chemoembolization and ethanol injection for advanced hepatocellular carcinoma Semin Oncol 24 2 suppl 6 1997 S6 S55
78. K. Dohmen, M. Shirahama, and H. Shigematsu Transcatheter arterial chemoembolization therapy combined with percutaneous ethanol injection for unresectable large hepatocellular carcinoma: an evaluation of the local therapeutic effect and survival rate Hepatogastrology 48 41 2001 1409 1415